Global Parenteral Drugs Packaging Market Research Report 2024

Publication ID:

PB505243008

Publication Date:

May 20, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Packaging [2]

Industry & Manufacturing [3]

Description:

The global Parenteral Drugs Packaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Parenteral Drugs Packaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral Drugs Packaging.
Report Scope
The Parenteral Drugs Packaging market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Parenteral Drugs Packaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parenteral Drugs Packaging manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ypsomed Holding AG
Gerresheimer AG
SiO2 Medical Products
Schott AG
Ompi Stevanato Group
Becton Dickinson and Company
MeadWestvaco Corporation
Unilife Corporation Inc
West Pharmaceutical Services
Terumo Corporation
Berry Plastics Corporation
Owens-Illinois
RPC Group
Graphic Packaging Group
Segment by Type
Polyvinyl Chloride (PVC)
Polyolefin
Segment by Application
Large Volume Parenteral (LVP)
Small Volume Parenteral (SVP)
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Parenteral Drugs Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Parenteral Drugs Packaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Parenteral Drugs Packaging Market Overview
1.1 Product Overview and Scope of Parenteral Drugs Packaging
1.2 Parenteral Drugs Packaging Segment by Type
1.2.1 Global Parenteral Drugs Packaging Market Value Comparison by Type (2024-2030)
1.2.2 Polyvinyl Chloride (PVC)
1.2.3 Polyolefin
1.3 Parenteral Drugs Packaging Segment by Application
1.3.1 Global Parenteral Drugs Packaging Market Value by Application: (2024-2030)
1.3.2 Large Volume Parenteral (LVP)
1.3.3 Small Volume Parenteral (SVP)
1.4 Global Parenteral Drugs Packaging Market Size Estimates and Forecasts
1.4.1 Global Parenteral Drugs Packaging Revenue 2019-2030
1.4.2 Global Parenteral Drugs Packaging Sales 2019-2030
1.4.3 Global Parenteral Drugs Packaging Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Parenteral Drugs Packaging Market Competition by Manufacturers
2.1 Global Parenteral Drugs Packaging Sales Market Share by Manufacturers (2019-2024)
2.2 Global Parenteral Drugs Packaging Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Parenteral Drugs Packaging Average Price by Manufacturers (2019-2024)
2.4 Global Parenteral Drugs Packaging Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Parenteral Drugs Packaging, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Parenteral Drugs Packaging, Product Type & Application
2.7 Parenteral Drugs Packaging Market Competitive Situation and Trends
2.7.1 Parenteral Drugs Packaging Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Parenteral Drugs Packaging Players Market Share by Revenue
2.7.3 Global Parenteral Drugs Packaging Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Parenteral Drugs Packaging Retrospective Market Scenario by Region
3.1 Global Parenteral Drugs Packaging Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Parenteral Drugs Packaging Global Parenteral Drugs Packaging Sales by Region: 2019-2030
3.2.1 Global Parenteral Drugs Packaging Sales by Region: 2019-2024
3.2.2 Global Parenteral Drugs Packaging Sales by Region: 2025-2030
3.3 Global Parenteral Drugs Packaging Global Parenteral Drugs Packaging Revenue by Region: 2019-2030
3.3.1 Global Parenteral Drugs Packaging Revenue by Region: 2019-2024
3.3.2 Global Parenteral Drugs Packaging Revenue by Region: 2025-2030
3.4 North America Parenteral Drugs Packaging Market Facts & Figures by Country
3.4.1 North America Parenteral Drugs Packaging Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Parenteral Drugs Packaging Sales by Country (2019-2030)
3.4.3 North America Parenteral Drugs Packaging Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Parenteral Drugs Packaging Market Facts & Figures by Country
3.5.1 Europe Parenteral Drugs Packaging Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Parenteral Drugs Packaging Sales by Country (2019-2030)
3.5.3 Europe Parenteral Drugs Packaging Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Parenteral Drugs Packaging Market Facts & Figures by Country
3.6.1 Asia Pacific Parenteral Drugs Packaging Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Parenteral Drugs Packaging Sales by Country (2019-2030)
3.6.3 Asia Pacific Parenteral Drugs Packaging Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Parenteral Drugs Packaging Market Facts & Figures by Country
3.7.1 Latin America Parenteral Drugs Packaging Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Parenteral Drugs Packaging Sales by Country (2019-2030)
3.7.3 Latin America Parenteral Drugs Packaging Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Parenteral Drugs Packaging Market Facts & Figures by Country
3.8.1 Middle East and Africa Parenteral Drugs Packaging Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Parenteral Drugs Packaging Sales by Country (2019-2030)
3.8.3 Middle East and Africa Parenteral Drugs Packaging Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Parenteral Drugs Packaging Sales by Type (2019-2030)
4.1.1 Global Parenteral Drugs Packaging Sales by Type (2019-2024)
4.1.2 Global Parenteral Drugs Packaging Sales by Type (2025-2030)
4.1.3 Global Parenteral Drugs Packaging Sales Market Share by Type (2019-2030)
4.2 Global Parenteral Drugs Packaging Revenue by Type (2019-2030)
4.2.1 Global Parenteral Drugs Packaging Revenue by Type (2019-2024)
4.2.2 Global Parenteral Drugs Packaging Revenue by Type (2025-2030)
4.2.3 Global Parenteral Drugs Packaging Revenue Market Share by Type (2019-2030)
4.3 Global Parenteral Drugs Packaging Price by Type (2019-2030)
5 Segment by Application
5.1 Global Parenteral Drugs Packaging Sales by Application (2019-2030)
5.1.1 Global Parenteral Drugs Packaging Sales by Application (2019-2024)
5.1.2 Global Parenteral Drugs Packaging Sales by Application (2025-2030)
5.1.3 Global Parenteral Drugs Packaging Sales Market Share by Application (2019-2030)
5.2 Global Parenteral Drugs Packaging Revenue by Application (2019-2030)
5.2.1 Global Parenteral Drugs Packaging Revenue by Application (2019-2024)
5.2.2 Global Parenteral Drugs Packaging Revenue by Application (2025-2030)
5.2.3 Global Parenteral Drugs Packaging Revenue Market Share by Application (2019-2030)
5.3 Global Parenteral Drugs Packaging Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ypsomed Holding AG
6.1.1 Ypsomed Holding AG Corporation Information
6.1.2 Ypsomed Holding AG Description and Business Overview
6.1.3 Ypsomed Holding AG Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ypsomed Holding AG Parenteral Drugs Packaging Product Portfolio
6.1.5 Ypsomed Holding AG Recent Developments/Updates
6.2 Gerresheimer AG
6.2.1 Gerresheimer AG Corporation Information
6.2.2 Gerresheimer AG Description and Business Overview
6.2.3 Gerresheimer AG Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Gerresheimer AG Parenteral Drugs Packaging Product Portfolio
6.2.5 Gerresheimer AG Recent Developments/Updates
6.3 SiO2 Medical Products
6.3.1 SiO2 Medical Products Corporation Information
6.3.2 SiO2 Medical Products Description and Business Overview
6.3.3 SiO2 Medical Products Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SiO2 Medical Products Parenteral Drugs Packaging Product Portfolio
6.3.5 SiO2 Medical Products Recent Developments/Updates
6.4 Schott AG
6.4.1 Schott AG Corporation Information
6.4.2 Schott AG Description and Business Overview
6.4.3 Schott AG Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Schott AG Parenteral Drugs Packaging Product Portfolio
6.4.5 Schott AG Recent Developments/Updates
6.5 Ompi Stevanato Group
6.5.1 Ompi Stevanato Group Corporation Information
6.5.2 Ompi Stevanato Group Description and Business Overview
6.5.3 Ompi Stevanato Group Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ompi Stevanato Group Parenteral Drugs Packaging Product Portfolio
6.5.5 Ompi Stevanato Group Recent Developments/Updates
6.6 Becton Dickinson and Company
6.6.1 Becton Dickinson and Company Corporation Information
6.6.2 Becton Dickinson and Company Description and Business Overview
6.6.3 Becton Dickinson and Company Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Becton Dickinson and Company Parenteral Drugs Packaging Product Portfolio
6.6.5 Becton Dickinson and Company Recent Developments/Updates
6.7 MeadWestvaco Corporation
6.6.1 MeadWestvaco Corporation Corporation Information
6.6.2 MeadWestvaco Corporation Description and Business Overview
6.6.3 MeadWestvaco Corporation Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MeadWestvaco Corporation Parenteral Drugs Packaging Product Portfolio
6.7.5 MeadWestvaco Corporation Recent Developments/Updates
6.8 Unilife Corporation Inc
6.8.1 Unilife Corporation Inc Corporation Information
6.8.2 Unilife Corporation Inc Description and Business Overview
6.8.3 Unilife Corporation Inc Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Unilife Corporation Inc Parenteral Drugs Packaging Product Portfolio
6.8.5 Unilife Corporation Inc Recent Developments/Updates
6.9 West Pharmaceutical Services
6.9.1 West Pharmaceutical Services Corporation Information
6.9.2 West Pharmaceutical Services Description and Business Overview
6.9.3 West Pharmaceutical Services Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2019-2024)
6.9.4 West Pharmaceutical Services Parenteral Drugs Packaging Product Portfolio
6.9.5 West Pharmaceutical Services Recent Developments/Updates
6.10 Terumo Corporation
6.10.1 Terumo Corporation Corporation Information
6.10.2 Terumo Corporation Description and Business Overview
6.10.3 Terumo Corporation Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Terumo Corporation Parenteral Drugs Packaging Product Portfolio
6.10.5 Terumo Corporation Recent Developments/Updates
6.11 Berry Plastics Corporation
6.11.1 Berry Plastics Corporation Corporation Information
6.11.2 Berry Plastics Corporation Parenteral Drugs Packaging Description and Business Overview
6.11.3 Berry Plastics Corporation Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Berry Plastics Corporation Parenteral Drugs Packaging Product Portfolio
6.11.5 Berry Plastics Corporation Recent Developments/Updates
6.12 Owens-Illinois
6.12.1 Owens-Illinois Corporation Information
6.12.2 Owens-Illinois Parenteral Drugs Packaging Description and Business Overview
6.12.3 Owens-Illinois Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Owens-Illinois Parenteral Drugs Packaging Product Portfolio
6.12.5 Owens-Illinois Recent Developments/Updates
6.13 RPC Group
6.13.1 RPC Group Corporation Information
6.13.2 RPC Group Parenteral Drugs Packaging Description and Business Overview
6.13.3 RPC Group Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2019-2024)
6.13.4 RPC Group Parenteral Drugs Packaging Product Portfolio
6.13.5 RPC Group Recent Developments/Updates
6.14 Graphic Packaging Group
6.14.1 Graphic Packaging Group Corporation Information
6.14.2 Graphic Packaging Group Parenteral Drugs Packaging Description and Business Overview
6.14.3 Graphic Packaging Group Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Graphic Packaging Group Parenteral Drugs Packaging Product Portfolio
6.14.5 Graphic Packaging Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Parenteral Drugs Packaging Industry Chain Analysis
7.2 Parenteral Drugs Packaging Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Parenteral Drugs Packaging Production Mode & Process
7.4 Parenteral Drugs Packaging Sales and Marketing
7.4.1 Parenteral Drugs Packaging Sales Channels
7.4.2 Parenteral Drugs Packaging Distributors
7.5 Parenteral Drugs Packaging Customers
8 Parenteral Drugs Packaging Market Dynamics
8.1 Parenteral Drugs Packaging Industry Trends
8.2 Parenteral Drugs Packaging Market Drivers
8.3 Parenteral Drugs Packaging Market Challenges
8.4 Parenteral Drugs Packaging Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Ypsomed Holding AG
Gerresheimer AG
SiO2 Medical Products
Schott AG
Ompi Stevanato Group
Becton Dickinson and Company
MeadWestvaco Corporation
Unilife Corporation Inc
West Pharmaceutical Services
Terumo Corporation
Berry Plastics Corporation
Owens-Illinois
RPC Group
Graphic Packaging Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂